Company news
Genedrive Plc (LSE:GDR) news
Genedrive Plc news releases on 6ix. Latest, Apr 5, 2017: Director/PDMR Shareholding - Replacement
Press releases — page 5
Director/PDMR Shareholding - Replacement
April 5, 2017
HCV Assay submitted for CE IVD Certification
March 27, 2017
Notice of Interim Results
March 24, 2017
Successful Clinical Results - Genedrive HCV Assay
March 8, 2017
Holdings in Company
February 6, 2017
Update on US Department of Defense Programme
January 16, 2017
Update on CFO Appointment
November 29, 2016
CE-IVD Certification for Human Genotyping Test
November 17, 2016
Preliminary Results for the year end 30 June 2016
October 11, 2016
Appointment of Chief Financial Officer
September 21, 2016
Genedrive Assay used in STOP-HCV-1 Clinical Trial
August 10, 2016
Re change of name, TIDM and website address
July 25, 2016
Result of General Meeting and Change of Name
July 11, 2016
Proposed Placing and Amendment to GHIF Bond
June 23, 2016
Business Update
June 7, 2016
Successful Clinical Trial of Genedrive®
May 3, 2016
Epistem Begins Full Commercial Launch of Genedrive
April 18, 2016
Funding award from US Department of Defense
March 21, 2016
Update on CEO Appointment
February 19, 2016
Announces Successful Assessment of Genedrive
February 18, 2016
Epistem Appoints David Budd as CEO
January 13, 2016
Preliminary Results for year ended 30 June 2015
October 28, 2015
Epistem Holdings Plc - Board Change
October 26, 2015
Pre-Close Trading Update and Board Changes
August 4, 2015
Issuance of Shares
June 8, 2015
NIH Response to UMB proposal
May 18, 2015
Regulatory Approval
April 23, 2015
Update re Indian regulatory approval
April 13, 2015
Extension of Director's Options Exercise Period
March 30, 2015
Half Yearly Report
March 26, 2015
Successful Completion of Genedrive Trials
October 28, 2014
Pre Close Trading Update
July 22, 2014
Directors' Shareholdings
January 7, 2014
Re Agreement
December 18, 2013
Annual Report & Accounts and Notice of AGM
November 26, 2013
Preliminary Results Date
October 1, 2013
EPISTEM RECEIVES PRESTIGIOUS FP7 GRANT AWARD
August 8, 2013
Senior Executive Incentive Package
March 26, 2013
Cash Placing
December 7, 2012
Pre-Close Trading Update
August 6, 2012
Professor Chris Potten
August 3, 2012
Director's Shareholding and Additional Listing
July 27, 2012
Tuberculosis test gains CE-IVD registration
July 5, 2012
Epistem Signs TB Channel Partner Agreement
March 5, 2012
Directors' shareholdings and issue of equity
December 19, 2011
2011 Annual Report and Accounts & Notice of AGM
November 9, 2011
Human DNA Identification Collaboration
October 5, 2011
GenedriveT passes first in-field Tuberculosis test
September 27, 2011
Tuberculosis Diagnostic Collaboration
June 28, 2011
Re Agreement - Replacement
March 17, 2011